LATAM Daily Brief
SEE OTHER BRANDS

Following the news from Latin America

LATAM Daily Brief: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on LATAM Daily Brief.

Press releases published on May 8, 2025

Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update

Celldex Reports First Quarter 2025 Financial Results and Provides Corporate Update

Strong execution and progress across pipeline with multiple key data read outs expected in 2025 Late breaking oral presentation on Phase 2 CSU program at EAACI 2025 in June Phase 3 barzolvolimab CSU studies enrollment ongoing; Phase 3 program in CIndU …

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Corvus Pharmaceuticals Announces Data from Cohorts 1-3 of Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis

Data continue to demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Data to be presented in an oral session and poster at the Society for Investigative Dermatology 2025 Annual …

MEDIAIPLUS leads data-driven solutions to close clinical trial information gaps

MEDIAIPLUS leads data-driven solutions to close clinical trial information gaps

MEDIAIPLUS uses AI to close clinical trial info gaps, offering data tools that match CROs, aid researchers, and support global pharma with smart solutions. PANGYO, GYEONGGI-DO, SOUTH KOREA, May 8, 2025 /⁨EINPresswire.com⁩/ -- Founded in 2019, MEDIAIPLUS …

Compromiso de IUX con la transparencia y la seguridad de los datos en el trading

Compromiso de IUX con la transparencia y la seguridad de los datos en el trading

IUX refuerza la protección de datos con medidas estrictas en la verificación de identidad y depósitos, asegurando la confidencialidad y seguridad. LIMASSOL, VINCENT, CYPRUS, May 8, 2025 /⁨EINPresswire.com⁩/ -- IUX presta una atención especial a la …

Latin Metals Appoints Eduardo Leon as Vice President of Exploration and Qualified Person

Latin Metals Appoints Eduardo Leon as Vice President of Exploration and Qualified Person

Upsizes Private Placement for Gross Proceeds of $1.3 Million Not for distribution to United States newswire services or for release, publication, distribution or dissemination directly, or indirectly, in whole or in part, in or into the United States. …

MEXC Lists USD1, Accelerating Global Stablecoin Innovation with World Liberty Financial

MEXC Lists USD1, Accelerating Global Stablecoin Innovation with World Liberty Financial

VICTORIA, Seychelles, May 08, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, announced that it will list World Liberty Financial USD (USD1) in the Innovation Zone on May 9, 2025 (UTC). The USD1/USDT trading pair will also open at …

Bluegrace Energy Bolivia to Finance 100% Green Energy System at FKF’s Industrial Facility in ZOFRATACNA, Peru

Bluegrace Energy Bolivia to Finance 100% Green Energy System at FKF’s Industrial Facility in ZOFRATACNA, Peru

Bluegrace backs FKF's shift to renewable energy with full funding for a solar and battery storage system at ZOFRATACNA’s Eco-Industrial Park in Peru. LONDON, GREATER LONDON, UNITED KINGDOM, May 8, 2025 /⁨EINPresswire.com⁩/ -- FRIGORÍFICOS KOBEFOOD S.A.C. …

KMT-Hansa Enters Into Memorandum of Understanding

KMT-Hansa Enters Into Memorandum of Understanding

TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- KMT-Hansa Corp. (the “Company”) is pleased to announce that it has entered into a memorandum of understanding (the “MOU”) with Astra Algorithm Limited (“Astra”), an arm’s length party to the Company. Astra is a …

Bitget Wallet Launches Full Support for Sei Network, Announces $700K Ecosystem Initiative

Bitget Wallet Launches Full Support for Sei Network, Announces $700K Ecosystem Initiative

SAN SALVADOR, El Salvador, May 08, 2025 (GLOBE NEWSWIRE) -- Bitget Wallet, a leading Web3 non-custodial wallet, now offers full support for the Sei network — expanding its multi-chain capabilities and making it easier for users globally to access and …

BBT: The World’s First Crypto Project Realizing Trump’s ‘Baby Bonus’

BBT: The World’s First Crypto Project Realizing Trump’s ‘Baby Bonus’

- BabyBoomToken (BBT), the AI-driven crypto tackling low birth rates, expands into South Korea - Backed by Elon Musk’s warnings and Trump’s policy vision, BBT leads a new era of population-focused tokens Donald Trump lifts a baby during a campaign rally in …

Veru Participates in a Virtual Investor KOL Connect Segment

Veru Participates in a Virtual Investor KOL Connect Segment

-- Moderated discussion with preeminent obesity expert, Louis J. Aronne, MD, FACP and Mitchell Steiner, M.D., F.A.C.S, President, CEO, and Founder, of Veru -- MIAMI, FL, May 08, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage …

Red Cat to Report Q1 2025 Earnings and Provide Corporate Update on Wednesday, May 14, 2025

Red Cat to Report Q1 2025 Earnings and Provide Corporate Update on Wednesday, May 14, 2025

SAN JUAN, Puerto Rico, May 08, 2025 (GLOBE NEWSWIRE) -- Red Cat (Nasdaq: RCAT) ("Red Cat" or the "Company"), a drone technology company integrating robotic hardware and software for military, government, and commercial operations, announces that financial …

AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists

AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists

OCALA, Fla., May 08, 2025 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (OTC Pink: AIMI) (“AIM” or the “Company”) today announced the presentation of clinical trial data involving AIM’s drug Ampligen by Pawel Kalinski, MD, PhD, at the recent …

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) 

GRI Bio’s Interim Biomarker Data Demonstrate Positive Trend Towards Anti-Fibrotic Effect of GRI-0621 in First Twelve Patients of Ongoing Phase 2a Study in Idiopathic Pulmonary Fibrosis (“IPF”) 

The Independent Data Monitoring Committee (IDMC) has recommended to continue the study as planned as there are no safety concerns seen in the data reviewed Continued momentum with completed patient enrollment for the 6-week interim analysis (N=24) and over …

HepaRegeniX Scientific Founder Covers HRX-215 Development and Clincial Data in Plenary at the European Association for the Study of the Liver Congress 2025

HepaRegeniX Scientific Founder Covers HRX-215 Development and Clincial Data in Plenary at the European Association for the Study of the Liver Congress 2025

Prof. Lars Zender’s featured talk described HepaRegeniX’s lead candidate and its potential in increasing liver regeneration, from initial target discovery and drug development towards Phase Ia clinical trial results Tuebingen, Germany, May 8, 2025 – …

ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update

Following announcement of prioritized development strategy for evorpacept in combination with anti-cancer antibodies at R…

Aligos Therapeutics Presents Positive Data at the EASL Congress 2025

Aligos Therapeutics Presents Positive Data at the EASL Congress 2025

SOUTH SAN FRANCISCO, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today …

PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting

PDS Biotech Announces Additional Details on Two Preclinical Universal Influenza Presentations at IMMUNOLOGY2025™ Annual Meeting

PRINCETON, N.J., May 08, 2025 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers and infectious …

ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)

ORYZON Awarded €13.26 Million Through the First Important Project of Common European Interest (IPCEI) in the Health Sector (Med4Cure Project)

Approximately 15 million USD Oryzon to validate epigenetic agents by applying a personalized medicine approach for rare and orphan diseases Oryzon will explore Aggression in specific subsets of Autism Spectrum Disorder (ASD) to expand the precision …

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide

PL BioScience Raises the Bar in Cell Culture Technology with First Artificial Human Platelet Lysate Worldwide

Worldwide first artificial Human Platelet Lysate (HPL) solution – a key ingredient for the research …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service